Avnish Bhatia, MD

Contact Dr. Bhatia

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 923-5676

Medical School
Drexel University College of Medicine - 2002

Residency
Beth Israel Medical Center, NY

Fellowship
Montefiore Medical Center, New York

Board Certification
Medical Oncology
Hematology
Internal Medicine

Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital

Hospital Appointment
Active Medical Staff

University Appointment
Clinical Assistant Professor of Medical Oncology

Research and Clinical Interests
Medical Oncology, Hematology-Oncology, Head & Neck Cancers, Esophageal Cancer, Lung Cancer

Publications

Most recent Peer-reviewed Publications

1. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome
2. HHV-8-associated multicentric castleman's disease in HIV negative patient: A novel therapy for an orphan disease
3. Rituximab in autoimmune pancytopenia: A case report and review of literature
4. A second case of myelodysplastic syndrome with t(9;12)(q22;p12) [1]
5. Aberrant blood grouping results in a patient with splenomegaly and thrombocytopenia
6. MYeloblast cells derived from MDS patient with capacity for continuous growth in vitro, autocrine GM-CSF production and resistance to FAS-induced apoptosis
7. Topotecan, fludarabine, aRA-C and G-CSF (T-FLAG) for aggressive myelodysplastic syndromes and acute myelogenous leukemia in the elderly: A dose finding for topotecan study
8. Case report of an unusually prolonged complete remission with fludarabine and cyclophosphamide followed by rituximab in refractory, previously treated, chronic lymphocytic leukemia
9. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)
10. Metastasis of an esophageal carcinoma to the soft tissue in the elbow
11. Treatment of primary defective iron-reutilization syndrome: Revisited
12. Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation
13. A pilot trial of 13-cis-retinoic acid and alpha-tocopherol with recombinant human erythropoietin in myelodysplastic syndrome patients with progressive or transfusion-dependent anemias
14. Is minimal residual disease in the peripheral-blood stem-cell transplantation of chronic myelogenous leukemia important? [2]
15. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM)
16. Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia
17. Interactive computer-based programs for a cancer learning center
18. Richter's syndrome associated with loss of response to transforming growth factor-beta
19. Anti-Baka neonatal alloimmune thrombocytopenia: Possible prevention by intravenous immunoglobulin
20. Hematologic effects of androgens revisited: An alternative therapy in various hematologic conditions

View All Publications